Compare StocksHCA vs NVDA

HCA Healthcare, Inc. (HCA) vs NVIDIA Corporation (NVDA): Which Is the Better Buy in 2026?

As of 2026-06-19, HCA is undervalued at $375, with a DCF intrinsic value of $523 and a margin of safety of 28%. NVDA is overvalued at $211, with an intrinsic value of $163 and a margin of safety of -29%. Of the two, HCA has the wider margin of safety.

HCA
HCA Healthcare, Inc.
$375.17
VS
NVDA
NVIDIA Corporation
$210.69

Rewards

HCA
  • HCA Healthcare, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • HCA Healthcare, Inc. scores 95/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • Free cash flow has grown at a 23.1% CAGR over the past 4 years, demonstrating strong earnings power growth.
NVDA
  • NVIDIA Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 74.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Free cash flow has grown at a 193.9% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

HCA
    NVDA
    • FCF yield of 1.9% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
    • Beneish M-Score of -1.06 flags financial patterns consistent with potential earnings manipulation — warrants further investigation.
    • 39 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

    Key Valuation Metrics

    Learn more →
    HCA
    NVDA
    Valuation
    $7.69B
    Free Cash Flow
    $96.68B
    9.24%
    FCF Yield
    1.89%
    12.93
    Trailing P/E
    32.26
    11.33
    Forward P/E
    16.55
    Quality & Moat
    18.14%
    ROIC
    63.06%
    N/A
    ROE
    114.29%
    41.61%
    Gross Margin
    74.14%
    1.20
    PEG Ratio
    0.64
    Balance Sheet Safety
    N/A
    Net Debt / Equity
    Net cash
    N/A
    Interest Coverage
    N/A
    3.13
    Net Debt / EBITDA
    -0.24
    0.76%
    Dividend Yield
    0.02%
    HCA: 4Ties: 1NVDA: 5
    HCANVDA

    Historical Fundamentals

    Learn more →
    HCA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    NVDA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    HCA
    $2.43
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $15.76B
    Δ Market Cap
    +$38.30B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    NVDA
    $17.68
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $220.50B
    Δ Market Cap
    +$3.90T
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    HCA
    28.2% Margin of Safety
    Price is 28.2% below estimated fair value
    Current Price: $375.17
    Fair Value: $522.55
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    NVDA
    44.3% Margin of Safety
    Price is 44.3% below estimated fair value
    Current Price: $210.69
    Fair Value: $378.18
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    HCA

    What growth rate is the market pricing in at $375?

    +7.3%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +5.6%

    The market implies +7.3% Owner Earnings growth, roughly in line with history — reasonably priced.

    Standard FCF implies +5.6%, reflecting ongoing growth investment.

    NVDA

    What growth rate is the market pricing in at $211?

    +17.9%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +20.8%

    The market implies +17.9% Owner Earnings growth, below historical trends — potential opportunity.

    Standard FCF implies a more demanding +20.8%, reflecting heavy growth investment expected to generate future returns.

    Economic Moat Score

    Learn more →
    HCA
    95/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
    NVDA
    69/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with roic consistency as the key competitive advantage. Improving revenue predictability would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    HCA
    -2.78
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    NVDA
    -1.06
    Likely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    HCA
    Insiders 16.2%Institutions 78.3%Retail & Other 5.5%
    No. of Institutional Holders1,952
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    NVDA
    Insiders 4.0%Institutions 70.9%Retail & Other 25.1%
    No. of Institutional Holders7,556
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    HCA
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    NVDA
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    HCA
    0
    Sells (3M)
    7
    Sells (12M)
    Total value (12M): $32.73M
    MCALEVEY MICHAEL R.
    Officer
    $903,537
    @ $533.37 · 2026-02-18
    WYATT CHRISTOPHER F
    Officer
    $2.02M
    @ $505.00 · 2026-02-11
    BERRES JENNIFER
    Officer
    $4.13M
    @ $514.58 · 2026-02-11
    HAZEN SAMUEL N
    Chief Executive Officer
    $21.48M
    @ $501.04 · 2026-02-03
    CUFFE MICHAEL S
    Officer
    $747,135
    @ $498.09 · 2026-02-03
    MCALEVEY MICHAEL R.
    Officer
    $1.84M
    @ $473.79 · 2025-11-05
    CUFFE MICHAEL S
    Officer
    $1.61M
    @ $418.84 · 2025-09-08
    FOSTER JON MARK
    Officer
    $5.80M
    @ $369.32 · 2025-05-13
    BERRES JENNIFER
    Officer
    $3.08M
    @ $322.59 · 2025-02-14
    BILLINGTON PHILLIP G
    Officer
    $1.36M
    @ $350.00 · 2024-11-14
    WHALEN KATHLEEN M
    Officer
    $527,677
    @ $357.99 · 2024-11-14
    AKDAMAR EROL R
    Officer
    $1.02M
    @ $353.00 · 2024-11-14
    CUFFE MICHAEL S
    Officer
    $3.22M
    @ $385.42 · 2024-09-12
    WHALEN KATHLEEN M
    Officer
    $1.76M
    @ $362.13 · 2024-07-31
    WYATT CHRISTOPHER F
    Officer
    $1.44M
    @ $360.20 · 2024-07-29
    REINER DEBORAH M
    Officer
    $1.19M
    @ $359.96 · 2024-07-29
    TORRES KATHRYN A
    Officer
    $659,328
    @ $355.05 · 2024-07-25
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    NVDA
    1
    Sells (3M)
    39
    Sells (12M)
    Total value (12M): $1.09B
    DABIRI JOHN O
    Director
    $133,750
    @ $214.00 · 2026-05-27
    ROBERTSON DONALD F JR
    Officer
    $942,944
    @ $174.75 · 2026-03-20
    SHAH AARTI S
    Director
    $3.36M
    @ $176.71 · 2026-03-19
    DABIRI JOHN O
    Director
    $555,440
    @ $184.90 · 2026-03-13
    ROBERTSON DONALD F JR
    Officer
    $15.19M
    @ $189.85 · 2026-01-02
    ROBERTSON DONALD F JR
    Officer
    $4.43M
    @ $179.98 · 2025-12-19
    DABIRI JOHN O
    Director
    $112,317
    @ $179.42 · 2025-11-24
    HUANG JEN-HSUN
    Chief Executive Officer
    $5.20M
    @ $207.91 · 2025-10-29
    HUANG JEN-HSUN
    Chief Executive Officer
    $23.56M
    @ $188.47 · 2025-10-28
    HUANG JEN-HSUN
    Chief Executive Officer
    $40.73M
    @ $181.04 · 2025-10-23
    HUANG JEN-HSUN
    Chief Executive Officer
    $41.06M
    @ $182.48 · 2025-10-20
    HUANG JEN-HSUN
    Chief Executive Officer
    $41.34M
    @ $183.73 · 2025-10-15
    HUANG JEN-HSUN
    Chief Executive Officer
    $42.89M
    @ $190.60 · 2025-10-10
    HUANG JEN-HSUN
    Chief Executive Officer
    $42.05M
    @ $186.89 · 2025-10-07
    HUANG JEN-HSUN
    Chief Executive Officer
    $42.09M
    @ $187.08 · 2025-10-02
    HUANG JEN-HSUN
    Chief Executive Officer
    $40.23M
    @ $178.82 · 2025-09-29
    HUANG JEN-HSUN
    Chief Executive Officer
    $40.21M
    @ $178.69 · 2025-09-24
    HUANG JEN-HSUN
    Chief Executive Officer
    $39.18M
    @ $174.14 · 2025-09-19
    ROBERTSON DONALD F JR
    Officer
    $617,298
    @ $176.37 · 2025-09-19
    HUANG JEN-HSUN
    Chief Executive Officer
    $39.75M
    @ $176.66 · 2025-09-16
    HUANG JEN-HSUN
    Chief Executive Officer
    $39.28M
    @ $174.59 · 2025-09-11
    HUANG JEN-HSUN
    Chief Executive Officer
    $38.01M
    @ $168.95 · 2025-09-08
    HUANG JEN-HSUN
    Chief Executive Officer
    $38.61M
    @ $171.60 · 2025-09-03
    HUDSON BEACH DAWN E
    Director
    $15.38M
    @ $170.90 · 2025-09-03
    HUANG JEN-HSUN
    Chief Executive Officer
    $27.12M
    @ $180.79 · 2025-08-15
    HUANG JEN-HSUN
    Chief Executive Officer
    $40.96M
    @ $182.04 · 2025-08-13
    HUANG JEN-HSUN
    Chief Executive Officer
    $40.66M
    @ $180.70 · 2025-08-08
    HUANG JEN-HSUN
    Chief Executive Officer
    $39.78M
    @ $176.80 · 2025-08-05
    HUANG JEN-HSUN
    Chief Executive Officer
    $40.18M
    @ $178.58 · 2025-07-31
    HUANG JEN-HSUN
    Chief Executive Officer
    $39.16M
    @ $174.02 · 2025-07-28
    HUANG JEN-HSUN
    Chief Executive Officer
    $38.22M
    @ $169.87 · 2025-07-23
    HUANG JEN-HSUN
    Chief Executive Officer
    $38.71M
    @ $172.05 · 2025-07-18
    HUANG JEN-HSUN
    Chief Executive Officer
    $37.59M
    @ $167.08 · 2025-07-15
    HUANG JEN-HSUN
    Chief Executive Officer
    $36.43M
    @ $161.91 · 2025-07-10
    HUANG JEN-HSUN
    Chief Executive Officer
    $35.55M
    @ $158.02 · 2025-07-07
    HUANG JEN-HSUN
    Chief Executive Officer
    $35.16M
    @ $156.27 · 2025-07-01
    HUANG JEN-HSUN
    Chief Executive Officer
    $30.47M
    @ $152.33 · 2025-06-26
    HUANG JEN-HSUN
    Chief Executive Officer
    $14.40M
    @ $144.04 · 2025-06-23
    ROBERTSON DONALD F JR
    Officer
    $646,469
    @ $143.66 · 2025-06-20
    BURGESS ROBERT KENNETH
    Director
    $6.74M
    @ $134.82 · 2025-05-30
    DABIRI JOHN O
    Director
    $91,608
    @ $138.80 · 2025-05-30
    KRESS COLETTE M.
    Chief Financial Officer
    $7.79M
    @ $116.83 · 2025-03-21
    ROBERTSON DONALD F JR
    Officer
    $525,585
    @ $116.80 · 2025-03-21
    SHAH AARTI S
    Director
    $2.37M
    @ $118.42 · 2025-03-20
    BURGESS ROBERT KENNETH
    Director
    $6.16M
    @ $115.49 · 2025-03-13
    DABIRI JOHN O
    Director
    $292,930
    @ $110.00 · 2025-03-10
    KRESS COLETTE M.
    Chief Financial Officer
    $9.03M
    @ $135.40 · 2024-12-13
    ROBERTSON DONALD F JR
    Officer
    $608,775
    @ $135.28 · 2024-12-13
    DABIRI JOHN O
    Director
    $101,672
    @ $142.00 · 2024-11-25
    KRESS COLETTE M.
    Chief Financial Officer
    $7.77M
    @ $116.59 · 2024-09-20
    ROBERTSON DONALD F JR
    Officer
    $524,293
    @ $116.51 · 2024-09-20
    HUANG JEN-HSUN
    Chief Executive Officer
    $28.55M
    @ $118.97 · 2024-09-13
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    HCA
    FearGreed
    😨Fear(39/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    NVDA
    FearGreed
    😐Neutral(56/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    HCA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (39)
    NVDA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
    View HCA Full AnalysisView NVDA Full Analysis

    Frequently Asked Questions: HCA vs NVDA

    Is HCA Healthcare, Inc. or NVIDIA Corporation more undervalued in 2026?

    Based on our discounted cash flow model, HCA trades at a 28.2% margin of safety (intrinsic value $523 vs. price $375), compared to NVDA's -29.0% margin of safety (intrinsic $163 vs. $211).

    Which stock has a wider economic moat, HCA Healthcare, Inc. or NVIDIA Corporation?

    HCA scores 95/100 (Wide moat), while NVDA scores 69/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is HCA Healthcare, Inc. in financial distress?

    HCA's Altman Z-Score of 2.7 places it in the Grey zone, signaling elevated bankruptcy risk. NVDA scores 66.7 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which company has better free cash flow, HCA Healthcare, Inc. or NVIDIA Corporation?

    HCA Healthcare, Inc. (HCA) generates a 9.2% free cash flow yield, compared to NVIDIA Corporation's 1.9%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, HCA Healthcare, Inc. or NVIDIA Corporation?

    NVDA earns 63.1% ROIC versus HCA's 18.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, HCA Healthcare, Inc.'s or NVIDIA Corporation's?

    HCA's dividend earns a safety score of 94/100 (Very Safe), compared to NVDA's 91/100 (Very Safe). HCA has raised its dividend for 3 consecutive years.

    Does NVIDIA Corporation have accounting red flags?

    NVDA's Beneish M-Score of -1.1 flags it as a likely earnings manipulator (above the -1.78 threshold). By contrast, HCA scores -2.8, within the normal range. The Beneish model detects aggressive accounting through eight financial ratios.